1 / 7

Demystifying the IRB Process: An Interactive Conversation with QIP

Learn about the IRB (Institutional Review Board) process and get assistance with study consultation, submission, and resolving regulatory issues. Attend QIP education sessions and request personalized trainings.

johnsondaniel
Download Presentation

Demystifying the IRB Process: An Interactive Conversation with QIP

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Demystifying the IRB Process: An Interactive Conversation with QIP Scott Meyers, CIP

  2. OHRA

  3. Quality Improvement Program (QIP) Services • Study Consultation: can meet with the research team to help anticipate and resolve regulatory issues that may hinder IRB review and approval Process • Submission Assistance: can assist with navigation and submission through ESTR, or help respond to IRB questions • QIP Education Series: monthly sessions during the academic year on various topics related to human research • In-service: available, by request, to conduct personalized group/department trainings • https://www.hsph.harvard.edu/ohra/quality-improvement-program-qip/

  4. IRB’sPrimaryFunction • To Ensure: • Participant Protection: • Rights and Welfare • Safety • Privacy and Confidentiality • Compliance with IRB-approved protocol, Institutional policies, and federal regulations • Function under federal Regulations 45 CFR 46 (HHS “Common Rule”) and 21 CFR parts 50, 46, 312 and 812 (FDA)

  5. Key Regulatory Definitions • Research is defined as a… “systematicinvestigation including research development, testing and evaluation, designed to develop or contribute to generalizable knowledge” • Human Subject is a… “living individual about whom an investigator (whether professional or student) conducting research obtains • Information or biospecimens through intervention/interaction with the individual, or • Uses, studies, analyzes, or generates identifiable private information or identifiable biospecimens” • Minimal Risk means… “that the probability and magnitude of harm or discomfort anticipated in the research are not greater in and of themselves than those ordinarily encountered in daily life or during the performance of routine physical or psychological examinations or tests.”

  6. Types of IRB Reviews & Determinations • Non-Full Board Review – on a rolling basis • Not Human Subjects Research determination • Exemption determination • Expedited approval • Full Board (Convened IRB) Review - monthly

  7. Common Confusions per your IRB Review Specialists • I don’t speak “IRB”…(IRB Jargon) • Why are you saying my research is not research? (QI vs Research) • What are these new Common Rule Changes? • Why are there so many rules for informed consent? When do I even need informed consent? • Why do I need a Reliance Agreement? • Are deidenitified and coded the same? • Are there really risks to participants in survey research? • Etc, etc, etc!

More Related